Medtronic plc.

Open: 90.46 Close: 90.69 Change: 0.23

Don't invest before reading what an AI found about Medtronic plc. Company Inc.

This document will help you to evaluate Medtronic plc. without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, trading, company, value, late, share, close, …

Concept Map

Semantic Network

Stock Summary

Medtronic plc develops, manufactures, and sells device-based medical therapies. Cardiovascular, medical, surgical, and Neuroscience Portfolio segments offer products for spinal surgeons, neurosurgeons, neurologists, neurologist, pain management.

Today's Summary

Longview partners guernsey ltd increases stake in medtronic ltd. by 36.3% amid stellar financial performance - best stocks. The company currently has a Zacks Rank of #3 (Hold)

Today's News

longview partners guernsey ltd increases stake in medtronic ltd. by 36.3% amid stellar financial performance - best stocks. According to its latest disclosure with the Securities & Exchange Commission, the firm now owns over 6.6 million shares of Medtronic stock, making it the companys 12th largest position and representing about 4.1% of Longviews portfolio. Medtronic closed the most recent trading day at $90.68, moving -0.3% from the previous trading session. The company currently has a Zacks Rank of #3 (Hold) Medtronic PLCs market value can be influenced by many factors that dont directly affect its underlying business (such as a pandemic or basic market pessimism) Market value can vary widely from intrinsic value, called intrinsic value. Correlation analysis and pair trading evaluation for Medtronic PLC can also be used as hedging techniques within a particular sector or industry to generate a better risk-adjusted return. Medtronic closed at $89.69 in the latest trading session, marking no change from the prior day. Wells Fargo analysts raised their price target for shares of the medical-technology company to $100 from $77. Medtronic plc (usa stocks:mdt) profitability? 2023 profitability analysis. Profitability drivers are factors that can directly affect your investment outlook on Medtronic PLC. Profitability trend refers to progression of profit or loss within a business. An upward trend means that Medtronics PLCs profit has generally increased over time, and a downward trend means profits are declining. Medtronic ( NYSE:MDT – Get Rating ) last announced its earnings results on Tuesday, February 21st. Hedge funds have recently modified their holdings of the company. Wells Fargo & Company upgraded Medtronic from an “equal weight” rating to an ‘overweight” and upped their price objective for the company from $77.00 to $100.00 in a research note on Monday. Medtronic climbed to No. 2 in DiversityInc Top 50 Companies List. The bold, innovative work of Medtronics LABS to reimagine global healthcare is being recognized in five categories of Fast Companys 2023 World Changing Ideas. Medtronic LABS is being honored as a 2023 finalist in the General Excellence , Health , and North America categories, with honorable mentions in Established Excellence and Mid-Sized Business. Hundreds of millions of people around the world still do not have access to quality healthcare Medtronic LABS Work Honored As World Changing by Fast Company. Analyst ratings 47% of 30 ratings Buy 46.7% Hold 46. 7% Sell 6% MDT Earnings $0.00 $1.56 per share. Medtronic (MDT) closed at $90.68 in the latest trading session, marking a -0.3% move from the prior day. The companys next earnings release is expected to be May 25, 2023, and analysts expect it to post earnings of $1. Shares of Medtronic PLC MDT, +0.51% inched 0.51%. The S&P 500 Index SPX fell 0.70% to 4,090.75 and Dow Jones Industrial Average DJIA, -0.80% to 33,414.24.

Stock Profile

"Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland."

Keywords

Are looking for the most relevant information about Medtronic plc.? Investor spend a lot of time searching for information to make investment decisions in Medtronic plc.. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Medtronic plc. are: Medtronic, trading, company, value, late, share, close, and the most common words in the summary are: medtronic, stock, market, plc, mdt, price, news, . One of the sentences in the summary was: The company currently has a Zacks Rank of #3 (Hold). Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #medtronic #stock #market #plc #mdt #price #news.